Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer

Jamie M. Jacobs, Emily A. Walsh, Chelsea S. Rapoport, Michael H. Antoni, Elyse R. Park, Kathryn Post, Amy Comander, Jeffrey Peppercorn, Steven A. Safren, Jennifer S. Temel, Joseph A. Greer

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Adjuvant endocrine therapy (AET) prevents recurrence after early stage, hormone sensitive breast cancer; however, adherence to AET is suboptimal, and efficacious interventions are severely lacking. Barriers to adherence are well established; however, interventions, thus, far have failed to produce meaningful changes in adherence and have generally not followed guiding principles of psychosocial intervention development. The purpose of this paper is to describe the iterative development, using the National Institutes of Health Stage Model for Behavioral Intervention Development, of an evidence-based, patient-centered, telehealth intervention to enhance adherence, improve symptom management, and reduce distress for patients taking AET after breast cancer, with a focus on (1) a small open pilot study which informed modifications and refinement of the intervention based on quantitative and qualitative patient feedback about feasibility and acceptability and (2) the underlying theoretical and empirical rationale for each component of the finalized intervention. Clinical implications and directions for future research are discussed.

Original languageEnglish (US)
JournalJournal of Clinical Psychology in Medical Settings
DOIs
StateAccepted/In press - 2020

Keywords

  • Adherence
  • Breast cancer
  • Cognitive-behavioral intervention
  • Distress
  • Hormonal therapy
  • Symptom management

ASJC Scopus subject areas

  • Clinical Psychology

Fingerprint Dive into the research topics of 'Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer'. Together they form a unique fingerprint.

Cite this